Abstract:Purpose: This study investigated the relationships of caveolin-1 expression with clinical pathologic parameters and the prognosis of patients with large cell lung carcinoma. This study also explored the roles of caveolin-1 in cell invasiveness, matrix metalloproteinase (MMP) expression, and non-small cell lung carcinoma activity in vitro.Methods: A total of 120 tissue samples were immunohistochemically analyzed for caveolin-1 expression. Cell invasion ability was measured by a Transwell invasion assay. Protein expression was assessed by Western blotting. MMP activity was detected by gelatin zymography.Results: Caveolin-1 was expressed in 54 of 120 (45.0%) cases of large cell lung carcinoma. Caveolin-1 expression was significantly correlated with node status (NO vs. N1, N2, and N3; P = 0.005) and advanced pTNM stage (Stages I and II vs. Stage III, P < 0.001). Patients with caveolin-l-positive expression had a poorer prognosis than did those with caveolin-1-negative expression (P < 0.001). The knockdown of caveolin-1 in H460 and 95D cells reduced the invasive ability of the cells and the expression of phosphorylated epidermal growth factor receptor (EGFR), phospho-extracellular signal-regulated kinases 1 and 2, MMP2, and MMP9; the protein level and activity of MMP2 and MMP9 were also decreased by the inhibition of EGFR activity in H460 and 95D cells.Conclusions: The expression of caveolin-1 was positively correlated with an advanced pathologic stage. Thus, caveolin-1 could act as a predictor of a poor prognosis in patients with large cell lung carcinoma. In addition, the downregulation of caveolin-1 reduced both the invasive ability of tumor cells and the protein and activity levels of MMP2 and MMP9 in vitro, suggesting the involvement of EGFR/MMP signaling in this process. (C) 2014 Elsevier GmbH. All rights reserved.

BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness.

BRCA1 regulation of transcription

BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells

Roles of BRCA1 and Its Interacting Proteins.

BRCA1 and cell signaling

Abstract #4440: BRCA1 Modulates Malignant Cell Behavior, the Expression of Survivin and Chemosensitivity in Human Breast Cancer Cells

BRCA1 regulates gene expression for orderly mitotic progression.

Down‐regulation of the Cavin Family Proteins in Breast Cancer

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

BRCA1 Regulates Transforming Growth Factor‐β (tgf‐β1) Signaling Through Gadd45a by Enhancing the Protein Stability of Smad4

BRCA1 is a negative modulator of the PRC2 complex.

Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells

BRCA1 negatively regulates miR-146a and inhibits its tumor promoting functions in breast cancer cells

BRCA1 As a Potential Human Prostate Tumor Suppressor: Modulation of Proliferation, Damage Responses and Expression of Cell Regulatory Proteins

Caveolin-1 Promotes an Invasive Phenotype and Predicts Poor Prognosis in Large Cell Lung Carcinoma.

Brca1 Suppresses Epithelial-To-Mesenchymal Transition And Stem Cell Dedifferentiation During Mammary And Tumor Development

Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.

Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

Regulation of the β‐catenin/LEF‐1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion

Negative Regulation Of Akt Activation By Brca1